RDNT

SEC Filing Summary: Primedex Health Systems, Inc. (10-Q)

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended July 31, 1998, and the nine-month period ended on that date. The registrant is Primedex Health Systems, Inc. (PHS), a provider of diagnostic imaging services. The filing includes consolidated results for PHS and its affiliates, including Radnet, Inc., Diagnostic Imaging Services, Inc. (DIS), and Radnet Managed Imaging Services, Inc. (RMIS). The financial statements are unaudited.

Key Financial Metrics

Note: Total Debt includes Notes and Leases Payable, Subordinated Debentures, and Cash Overdraft.

Material Changes vs. Prior Period

• Operational Turnaround: The company moved from an operating loss of $5.78 million in the prior year to a near-break-even operating income of $29,738. This improvement is primarily due to the absence of a $4.95 million impairment loss recorded in the prior year related to the closure of the Parkside facility.
• Revenue Decline: Net revenue decreased by approximately 12.6% year-over-year. This decline is attributed to the sale of the Future Diagnostics, Inc. (FDI) subsidiary in late 1997 and the divestiture of DIS's ultrasound division and four MRI facilities to Diagnostic Health Services, Inc. (DHS).
• Expense Reduction: Total operating expenses decreased by approximately $12.4 million, driven by the divestitures mentioned above and the elimination of the Parkside impairment charge.
• Debt Restructuring: The company incurred $630,000 in other expenses related to debt restructuring, which reduced future interest rates and extended payment terms. Additionally, the company repurchased $1.485 million of subordinated bond debentures, resulting in a $1.04 million extraordinary gain.

Guidance, Outlook, and Risks

• Liquidity Concerns: The company reported a significant working capital deficit of $19.66 million, an increase of $7.6 million from the prior year-end. This is largely due to increased borrowings against lines of credit and cash overdrafts.
• Debt Obligations: Future debt and capital lease payments over the next five years are projected to total approximately $85.9 million (excluding lines of credit). The company relies on two lines of credit totaling $15 million, with $13.04 million outstanding as of July 31, 1998.
• Strategic Consolidation: PHS plans to consolidate three Tower locations in Beverly Hills into a new facility in fiscal 1999 to reduce rental costs by approximately $1.015 million annually. There is uncertainty regarding the impact of this move on patient volume.
• Legal Contingencies:
  • Sterling Arbitration: DIS is facing a $5 million arbitration claim from Sterling Diagnostic Imaging regarding an alleged breach of a film purchase contract. Management intends to vigorously defend the claim.
  • Securities Litigation: A class action lawsuit ("In re Hibbard Brown & Company") remains pending, though a preliminary settlement of $240,000 was reached in 1996 and management expects no additional costs.
• Accounting Changes: The adoption of SOP 98-5 resulted in a $780,000 write-off of start-up costs, reducing net income by $0.02 per share.

Investor Verification Checklist

• Debt Covenants: Verify compliance with the two primary lines of credit, which are secured by accounts receivable and personally guaranteed by the CEO.
• Legal Exposure: Monitor the status of the $5 million Sterling Diagnostic Imaging arbitration claim.
• Revenue Sustainability: Assess whether the revenue decline from divestitures is offset by growth in remaining centers (e.g., Radnet, Woodward Park, Oxnard).
• Consolidation Impact: Track the financial performance of the three Tower locations post-consolidation into the new Wilshire facility in fiscal 1999.
• Cash Burn Rate: Review the ability to service $85.9 million in future debt obligations given the current negative operating cash flow.